BioWorld-International-2011-02-16
European IPO Window Open? Philogen Files $89.6M Offering
eTherapeutics Raises $33.6M, London's Invesco to Own 47.7%
LONDON eTherapeutics plc achieved the seemingly impossible, raising £21 million (US$33.6 million) in a placment at a premium to the closing price on Monday, the day before the deal was announced. (BioWorld International)

